NCT07836881

Brief Summary

This study evaluated red blood cell function and aerobic capacity in adults receiving maintenance hemodialysis and in healthy reference participants. Participants receiving hemodialysis were included in either a supervised exercise training group or a usual-care group. The supervised exercise program combined resistance and aerobic exercise performed before hemodialysis. Participants in the exercise group completed repeated assessments across a non-exercise observation period, exercise training, and post-training follow-up. The usual-care group continued usual care without supervised exercise training, and healthy participants served as a reference group. Assessments included cardiopulmonary exercise testing and blood sampling to evaluate aerobic capacity, red blood cell deformability, and red blood cell characteristics related to membrane function, cell shape, oxidative stress, and calcium-related responses.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
63

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 24, 2022

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 28, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 28, 2025

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

September 12, 2026

Completed
11 days until next milestone

First Posted

Study publicly available on registry

September 23, 2026

Completed
Last Updated

September 23, 2026

Status Verified

September 1, 2026

Enrollment Period

3.3 years

First QC Date

September 12, 2026

Last Update Submit

September 17, 2026

Conditions

Keywords

Exercise TrainingHemodialysisRed Blood CellAerobic CapacityErythrocyte Deformability

Outcome Measures

Primary Outcomes (5)

  • Change in Maximal Erythrocyte Elongation Index (EImax)

    Maximal erythrocyte elongation index (EImax) was derived from ektacytometry measurements obtained across increasing shear stress.

    Baseline (study entry); 3 months after baseline (pre-training); mid-training after 36 supervised exercise sessions; end of training after 72 supervised exercise sessions; and 3 months after training cessation

  • Change in Shear Stress at One-Half Maximal Erythrocyte Deformation (SS1/2)

    The shear stress required to achieve one-half of maximal erythrocyte deformation (SS1/2) was derived from ektacytometry measurements across increasing shear stress.

    Baseline (study entry); 3 months after baseline (pre-training); mid-training after 36 supervised exercise sessions; end of training after 72 supervised exercise sessions; and 3 months after training cessation

  • Change in Hypertonic Osmolality at 50% of Maximal Elongation Index (Ohyper)

    Ohyper was assessed by osmotic-gradient ektacytometry and defined as the hypertonic osmolality at 50% of maximal erythrocyte elongation index.

    Baseline (study entry); 3 months after baseline (pre-training); mid-training after 36 supervised exercise sessions; end of training after 72 supervised exercise sessions; and 3 months after training cessation

  • Change in Osmolality at Maximal Elongation Index (Omax)

    Omax was assessed by osmotic-gradient ektacytometry and defined as the osmolality at maximal erythrocyte elongation index.

    Baseline (study entry); 3 months after baseline (pre-training); mid-training after 36 supervised exercise sessions; end of training after 72 supervised exercise sessions; and 3 months after training cessation

  • Change in Osmoscan Area Under the Elongation Index-Osmolality Curve

    Osmoscan area was assessed by osmotic-gradient ektacytometry and defined as the area under the erythrocyte elongation index-osmolality curve.

    Baseline (study entry); 3 months after baseline (pre-training); mid-training after 36 supervised exercise sessions; end of training after 72 supervised exercise sessions; and 3 months after training cessation

Secondary Outcomes (5)

  • Change in Peak Oxygen Uptake (Peak VO₂/kg) Assessed by Cardiopulmonary Exercise Testing

    Baseline; 3 months after baseline; after 36 supervised exercise sessions (mid-training); after 72 supervised exercise sessions (end of training); and 3 months after training cessation

  • Change in Erythrocyte Cellular Characteristics

    Baseline (study entry); 3 months after baseline (pre-training); mid-training after 36 supervised exercise sessions; end of training after 72 supervised exercise sessions; and 3 months after training cessation

  • Change in Gardos-Related Erythrocyte Deformability Response

    Baseline (study entry); 3 months after baseline (pre-training); mid-training after 36 supervised exercise sessions; end of training after 72 supervised exercise sessions; and 3 months after training cessation

  • Change in Erythrocyte Intracellular Calcium Response to Oxidative Stress

    Baseline (study entry); 3 months after baseline (pre-training); mid-training after 36 supervised exercise sessions; end of training after 72 supervised exercise sessions; and 3 months after training cessation

  • Change in Erythrocyte Side-Scatter Response to Oxidative Stress

    Baseline (study entry); 3 months after baseline (pre-training); mid-training after 36 supervised exercise sessions; end of training after 72 supervised exercise sessions; and 3 months after training cessation

Study Arms (3)

Supervised Exercise Training

EXPERIMENTAL

Participants receiving maintenance hemodialysis underwent supervised pre-dialysis exercise training combining aerobic and resistance exercise. Training was performed two to three times per week, with a target of 72 supervised sessions.

Behavioral: Supervised Exercise Training

Usual Care

NO INTERVENTION

Participants receiving maintenance hemodialysis continued usual medical care and maintained their usual daily activities without supervised exercise training during the intervention period.

Healthy Reference

NO INTERVENTION

Healthy participants without kidney disease received no exercise intervention and underwent study assessments to provide reference data for physiological and red blood cell measurements.

Interventions

Supervised pre-dialysis exercise training combining aerobic and resistance exercise was performed two to three times per week. Each session included aerobic exercise using a cycle ergometer, recumbent stepper, or treadmill, together with resistance exercises targeting the upper limbs, lower limbs, and trunk. Exercise intensity was prescribed according to cardiopulmonary exercise testing and adjusted according to participant tolerance and clinical status. Training was conducted approximately 1 to 2 hours before hemodialysis, with a target of 72 supervised exercise sessions.

Supervised Exercise Training

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 20 years or older
  • For participants with end-stage renal disease: maintenance hemodialysis for more than 6 months, clinically stable during the previous 3 months, stable medical treatment for at least 6 weeks, nephrologist approval for participation, and Kt/V \>1.2.
  • For healthy reference participants: no history of kidney disease.
  • Willingness to provide written informed consent.

You may not qualify if:

  • Hyperkalemia within the previous 3 months.
  • Orthopedic disease, muscle weakness, or other medical, physiological, or psychological conditions preventing exercise training or exercise testing.
  • Pregnancy or planned pregnancy within 1 year.
  • Implanted cardiac devices that prevented achievement of the heart rate required for exercise training.
  • Cardiovascular, metabolic, or other clinical contraindications to exercise testing or training.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chang Gung Memorial Hospital

Taoyuan, Taiwan

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

September 12, 2026

First Posted

September 23, 2026

Study Start

August 24, 2022

Primary Completion

December 28, 2025

Study Completion

December 28, 2025

Last Updated

September 23, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will not share

Locations